For the treatment of pleural mesothelioma, adenoviruses delivering two different subtypes of type I IFNs have been employed: IFN-β (rAd-IFNβ) and IFN- α2b (rAd- IFNα2b). This evidence concerns the gene IFNA2 and pleural mesothelioma.